Obesity and obesity-associated metabolic disease conditions in Connemara ponies in Ireland

被引:2
|
作者
Al-Ansari, Ahmed Saleh [1 ]
Golding, Emma [1 ]
Walshe, Nicola [1 ]
Mooney, Carmel T. [1 ]
Duggan, Vivienne [1 ]
机构
[1] Univ Coll Dublin, Sch Vet Med, Dublin, Ireland
关键词
Connemara pony; EMS; horse; hyperinsulinaemia; insulin dysregulation; laminitis; obesity; INSULIN; LAMINITIS; HORSES; RISK;
D O I
10.1111/evj.14029
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: Equine obesity combined with insulin dysregulation (ID) is a major risk factor associated with laminitis. Some pony breeds appear to be at increased risk. However, little is known regarding the prevalence of obesity or hyperinsulinaemia as evidence of ID in Irish ponies.Objective: To investigate the prevalence of obesity and associated endocrine/metabolic disease conditions in Connemara ponies and to determine if hyperinsulinaemia in these ponies could be predicted by morphometric or metabolic markers.Study design: Cross-sectional study.Methods: The study population included registered Connemara ponies recruited through public and veterinary social media posts. Ponies underwent a physical examination and information on their management and clinical history was obtained via owner questionnaire. The body condition score (BCS) was measured using the Henneke system; cresty neck score (CNS) and regionalised adiposity were also assessed. Hyperinsulinaemia was confirmed by measuring serum basal insulin concentration (BIC) or insulin concentration after an oral sugar test (OST). Blood glucose and triglyceride concentrations were measured. Characteristics of hyperinsulinaemic and insulin-sensitive ponies were compared by logistic regression.Results: Two hundred ponies were included; 59 ponies (29.5%) had a BCS >= 7, 58 (29.0%) had a CNS >= 2.5 and 135 (67.5%) had regionalised adiposity; 137 (68.5%) ponies had at least one of these abnormalities. Owner-reported history or clinical evidence of chronic laminitis was found in 92 ponies (46.0%). Hyperinsulinaemia was confirmed in 32 ponies (16.0%), including 23 of 91 (25.3%) detected by OST and 9 of 109 (8.3%) by BIC. Hypertriglyceridaemia was observed in 12 of 198 ponies (6.1%) ponies and hyperglycaemia in 11 of 197 ponies (5.6%) ponies. The odds of hyperinsulinaemia increased by a factor of 6.53 (95% confidence interval: 2.95, 15.21) when BCS was >= 7.Main limitations: The OST was not performed in all ponies.Conclusions: Increased adiposity, laminitis and metabolic derangements are prevalent in this native Irish pony breed.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [21] Extracellular miRNAs as mediators of obesity-associated disease
    Brandao, Bruna Brasil
    Lino, Marsel
    Kahn, C. Ronald
    JOURNAL OF PHYSIOLOGY-LONDON, 2022, 600 (05): : 1155 - 1169
  • [22] Targeting Autophagy in Obesity-Associated Heart Disease
    Castaneda, Diana
    Gabani, Mohanad
    Choi, Soo-Kyoung
    Quynh My Nguyen
    Chen, Cheng
    Mapara, Ayesha
    Kassan, Adam
    Gonzalez, Alexis A.
    Ait-Aissa, Karima
    Kassan, Modar
    OBESITY, 2019, 27 (07) : 1050 - 1058
  • [23] Obesity-associated autoreactivity
    Bird, Lucy
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (10) : 595 - 595
  • [24] Obesity-Associated Nonalcoholic Fatty Liver Disease
    Yilmaz, Yusuf
    Younossi, Zobair M.
    CLINICS IN LIVER DISEASE, 2014, 18 (01) : 19 - +
  • [25] Obesity-associated Morbidity
    Choi, Kwang Hae
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2008, 11 : 149 - 152
  • [26] The New Challenge of Obesity - Obesity-Associated Nephropathy
    Hao, Mengjin
    Lv, You
    Liu, Siyuan
    Guo, Weiying
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 1957 - 1971
  • [27] Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation
    Pessentheiner, Ariane R.
    Ducasa, G. Michelle
    Gordts, Philip L. S. M.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [28] Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
    Longo, Michele
    Zatterale, Federica
    Naderi, Jamal
    Parrillo, Luca
    Formisano, Pietro
    Raciti, Gregory Alexander
    Beguinot, Francesco
    Miele, Claudia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [29] Dopaminergic pathways in obesity-associated immuno-metabolic depression
    Leite, Fernanda
    Leite, Angela
    Rasini, Emanuela
    Gaiazzi, Michela
    Ribeiro, Laura
    Marino, Franca
    Cosentino, Marco
    PSYCHOLOGICAL MEDICINE, 2018, 48 (13) : 2273 - 2275
  • [30] Fusion Gene-Based Therapy for Prevention and Treatment of Obesity and Obesity-Associated Metabolic Diseases
    Yang, Yueze
    Gao, Mingming
    Liu, Huan
    Zhang, Guisheng
    Liu, Dexi
    MOLECULAR THERAPY, 2020, 28 (04) : 235 - 236